Article (Scientific journals)
Protection cardio-renale par les inhibiteurs des SGLT2 (gliflozines) : d'EMPA-REG OUTCOME a CANVAS.
Scheen, André; Ernest, Philippe; Jandrain, Bernard
2017In Revue Médicale Suisse, 13 (571), p. 1421-1426
Peer Reviewed verified by ORBi
 

Files


Full Text
2017 RMS Protection cardio-rénale.pdf
Publisher postprint (121.31 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] The cardiovascular (CV) and renal protection reported with empagliflozin in EMPA-REG OUTCOME is now confirmed with canagliflozin in CANVAS in patients with type 2 diabetes and high cardiovascular risk: similar and significant reductions in major CV events (-14 vs. -14%), in hospitalisations for heart failure (-35 vs. -33%) and in renal events (-39 vs. -40%). The greater reduction in CV mortality (-38 vs. - 13%) and all-cause mortality (-32 vs. -13%) in EMPA-REG OUTCOME than in CANVAS may be explained by the greater proportion of patients with CV disease (secondary prevention : 99 vs. 65%). In contrast to EMPA-REG OUTCOME, CANVAS did not show an increase in stroke (-10%, NS), but reported a higher rate of fractures and amputations with canagliflozin. Overall, these results support a class effect for the cardiorenal protection by inhibitors of sodium-glucose type 2 (SGLT2) cotransporters.
Disciplines :
Pharmacy, pharmacology & toxicology
Endocrinology, metabolism & nutrition
Author, co-author :
Scheen, André  ;  Université de Liège > Département des sciences cliniques > Département des sciences cliniques
Ernest, Philippe 
Jandrain, Bernard ;  Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de diabétologie, nutrition, maladies métaboliques
Language :
French
Title :
Protection cardio-renale par les inhibiteurs des SGLT2 (gliflozines) : d'EMPA-REG OUTCOME a CANVAS.
Alternative titles :
[en] Cardiorenal protection with SGLT2 inhibitors (gliflozins) : from EMPA-REG OUTCOME to CANVAS
Publication date :
2017
Journal title :
Revue Médicale Suisse
ISSN :
1660-9379
Publisher :
Medecine et Hygiène, Switzerland
Volume :
13
Issue :
571
Pages :
1421-1426
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 08 October 2017

Statistics


Number of views
1049 (12 by ULiège)
Number of downloads
1048 (7 by ULiège)

Scopus citations®
 
9
Scopus citations®
without self-citations
1

Bibliography


Similar publications



Contact ORBi